223 related articles for article (PubMed ID: 20824463)
1. Advocacy groups and their role in rare diseases research.
Dunkle M; Pines W; Saltonstall PL
Adv Exp Med Biol; 2010; 686():515-25. PubMed ID: 20824463
[TBL] [Abstract][Full Text] [Related]
2. New and evolving rare diseases research programs at the National Institutes of Health.
Groft SC; Rubinstein YR
Public Health Genomics; 2013; 16(6):259-67. PubMed ID: 24503586
[TBL] [Abstract][Full Text] [Related]
3. Rare diseases, orphan drugs, and orphaned patients.
Scheindlin S
Mol Interv; 2006 Aug; 6(4):186-91. PubMed ID: 16960139
[No Abstract] [Full Text] [Related]
4. Rare diseases research: expanding collaborative translational research opportunities.
Groft SC
Chest; 2013 Jul; 144(1):16-23. PubMed ID: 23880676
[TBL] [Abstract][Full Text] [Related]
5. Review of 11 national policies for rare diseases in the context of key patient needs.
Dharssi S; Wong-Rieger D; Harold M; Terry S
Orphanet J Rare Dis; 2017 Mar; 12(1):63. PubMed ID: 28359278
[TBL] [Abstract][Full Text] [Related]
6. Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data.
Groft SC; Posada de la Paz M
Adv Exp Med Biol; 2017; 1031():3-21. PubMed ID: 29214563
[TBL] [Abstract][Full Text] [Related]
7. Post-approval Studies for Rare Disease Treatments and Orphan Drugs.
Maier WC; Christensen RA; Anderson P
Adv Exp Med Biol; 2017; 1031():197-205. PubMed ID: 29214573
[TBL] [Abstract][Full Text] [Related]
8. Developing treatments for inborn errors: incentives available to the clinician.
Haffner ME
Mol Genet Metab; 2004 Apr; 81 Suppl 1():S63-6. PubMed ID: 15050976
[TBL] [Abstract][Full Text] [Related]
9. Novel Treatments for Rare Cancers: The U.S. Orphan Drug Act Is Delivering-A Cross-Sectional Analysis.
Stockklausner C; Lampert A; Hoffmann GF; Ries M
Oncologist; 2016 Apr; 21(4):487-93. PubMed ID: 27022038
[TBL] [Abstract][Full Text] [Related]
10. Navigating through orphan medicinal product regulations in EU and US--similarities and differences.
Tiwari J
Regul Toxicol Pharmacol; 2015 Feb; 71(1):63-7. PubMed ID: 25497996
[TBL] [Abstract][Full Text] [Related]
11. Drug development for orphan diseases in the context of personalized medicine.
Brewer GJ
Transl Res; 2009 Dec; 154(6):314-22. PubMed ID: 19931198
[TBL] [Abstract][Full Text] [Related]
12. A cross-national comparative study of orphan drug policies in the United States, the European Union, and Japan: towards a made-in-China orphan drug policy.
Liu BC; He L; He G; He Y
J Public Health Policy; 2010 Dec; 31(4):407-20; discussion 420-1. PubMed ID: 21119648
[TBL] [Abstract][Full Text] [Related]
13. Patients mutiny against Orphan Drug Act.
Margolid RE
Healthspan; 1992 Feb; 9(2):25-6. PubMed ID: 10117860
[No Abstract] [Full Text] [Related]
14. "Creating hope" and other incentives for drug development for children.
Connor E; Cure P
Sci Transl Med; 2011 Jan; 3(66):66cm1. PubMed ID: 21248312
[TBL] [Abstract][Full Text] [Related]
15. The impact of the Orphan Drug Act on the development and advancement of neurological products for rare diseases: a descriptive review.
Burke KA; Freeman SN; Imoisili MA; Coté TR
Clin Pharmacol Ther; 2010 Oct; 88(4):449-53. PubMed ID: 20856241
[TBL] [Abstract][Full Text] [Related]
16. Orphan drugs and orphan tests in the USA.
Thoene JG
Community Genet; 2004; 7(4):169-72. PubMed ID: 15692190
[No Abstract] [Full Text] [Related]
17. The loneliness of fighting a rare cancer.
Dockser Marcus A
Health Aff (Millwood); 2010; 29(1):203-6. PubMed ID: 20048378
[TBL] [Abstract][Full Text] [Related]
18. Orphan products development and some methods for maximizing the usefulness of research on rare diseases.
Finkel MJ
Prog Clin Biol Res; 1985; 197():11-8. PubMed ID: 4070285
[No Abstract] [Full Text] [Related]
19. How did uncommon disorders become 'rare diseases'? History of a boundary object.
Huyard C
Sociol Health Illn; 2009 May; 31(4):463-77. PubMed ID: 19397760
[TBL] [Abstract][Full Text] [Related]
20. Pressure for drug development in lysosomal storage disorders - a quantitative analysis thirty years beyond the US orphan drug act.
Mechler K; Mountford WK; Hoffmann GF; Ries M
Orphanet J Rare Dis; 2015 Apr; 10():46. PubMed ID: 25896727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
